Pharming's Joenja has become the first disease-modifying drug that can be used by the NHS to treat activated phosphoinositide ...

The platform's library of specialised life sciences agents creates an adaptable framework that breaks down silos between data ...

Zurich-based startup Veraxa Biotech has reached a deal to merge with special purpose acquisition company (SPAC) Voyager, ...

The new data – from the ARISE trial – found that Cobenfy wasn't statistically better than placebo at improving the widely ...

PE-backed specialty pharma company Kelso Pharma, which recently acquired Italian medical device and pharma company Velit ...

Health and Human Services (HHS) Secretary Robert F Kennedy Jr, who oversees the FDA, has made no secret of his desire to ban ...

Roche has picked up a CE Mark approval in the EU for an artificial intelligence algorithm that can help doctors decide whether patients presenting with acute chest pain are having a heart attack.

For companies in the biotech space, it’s never been easy to navigate the legal and business risks inherent in a highly ...

Clinical trial success rates are very low, with up to 95% not succeeding, and a wide range of disease states remains ...

Sky Labs' CART-I ring – described as a cardio tracker – achieved 84.6% sensitivity compared to 69.1% for the Apple Watch, ...

Enhertu is already approved as a second-line or later therapy for HER2-positive breast cancer based on the results of the ...

At the American Urological Association (AUA) that starts later this week, J&J is scheduled to report that TAR-200 achieved a ...